BioCatalystWatch
TOVXWorkspace / TOVX / OverviewCompany library
Theriva Biologics, Inc. logo

Theriva Biologics, Inc.

Theriva Biologics, Inc. (TOVX)

Website

Price
Market cap
Next catalystExpected Q4 2026VCN-01 + gemcitabine/nab-paclitaxel — VIRAGE2 · Enrollment completionSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

VCN-01 (zabilugene almadenorepvec)VCN-01 + gemcitabine/nab-paclitaxel — VIRAGE2

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

VCN-01 (zabilugene almadenorepvec)

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

VCN-01 (zabilugene almadenorepvec)VCN-01 + gemcitabine/nab-paclitaxel — VIRAGE2

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

VCN-01 (zabilugene almadenorepvec)

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

VCN-11

PreINDP1P2P3FilingApproved
VCN-12

PreINDP1P2P3FilingApproved

Partner / License out

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

History / paused

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TOVX PR & News

PR & News

Theriva Biologics, Inc.
Theriva Biologics, Inc.
Theriva Biologics, Inc.

TOVX SEC archive